6 results on '"Bhatia, Anuj"'
Search Results
2. Evaluating the impact of gabapentinoids on sleep health in patients with chronic neuropathic pain: a systematic review and meta-analysis.
- Author
-
Kapustin, Daniel, Bhatia, Anuj, McParland, Aidan, Trivedi, Aditya, Davidson, Alexandra, Brull, Richard, and Singh, Mandeep
- Subjects
- *
QUALITY of life , *MENTAL health , *CHRONIC pain & psychology , *CHRONIC pain , *RESEARCH , *PAIN measurement , *META-analysis , *ANALGESICS , *NEURALGIA , *RESEARCH methodology , *SYSTEMATIC reviews , *EVALUATION research , *MEDICAL cooperation , *SLEEP , *TREATMENT effectiveness , *COMPARATIVE studies , *PHARMACODYNAMICS - Abstract
Chronic neuropathic pain (NP) is debilitating and impacts sleep health and quality of life. Treatment with gabapentinoids (GBs) has been shown to reduce pain, but its effects on sleep health have not been systematically evaluated. The objective of this systematic review and meta-analysis was to assess the relationship between GB therapy dose and duration on sleep quality, daytime somnolence, and intensity of pain in patients with NP. Subgroup comparisons were planned for high- vs low-dose GBs, where 300 mg per day or more of pregabalin was used to classify high-dose therapy. Trial data were segregated by duration less than 6 weeks and 6 weeks or greater. Twenty randomized controlled trials were included. Primary outcome measures included pain-related sleep interference and incidence of daytime somnolence. Secondary outcomes included daily pain scores (numerical rating scale 0-10) and patient global impression of change. Significant improvement in sleep quality was observed after 6 weeks of GB treatment when compared with placebo (standardized mean difference 0.39, 95% confidence interval 0.32-0.46 P < 0.001). Increased daytime somnolence was observed among all GB-treated groups when compared with placebo. Treated patients were also more likely to report improvement of patient global impression of change scores. Pain scores decreased significantly in patients both after 6 weeks of treatment (P < 0.001) and in trials less than 6 weeks (P = 0.017) when compared with placebo. Our data demonstrate that GBs have a positive impact on sleep health, quality of life, and pain in patients with NP syndromes. However, these benefits come at the expense of daytime somnolence. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
3. Effect of intraoperative magnesium infusion on perioperative analgesia in open cholecystectomy
- Author
-
Bhatia, Anuj, Kashyap, Lokesh, Pawar, Dilip K, and Trikha, Anjan
- Subjects
- *
SURGICAL complications , *CHOLECYSTECTOMY , *GALLBLADDER surgery , *ANALGESIA - Abstract
Study objective: To study the role of magnesium sulphate (MgSO4) on analgesic requirement, pain, discomfort, and sleep during perioperative period.Design: prospective, double-blinded, randomized study.Settings: Operating room and recovery ward at a university teaching hospital.Patients: 50 ASA physical status I and II patients scheduled for elective open cholecystectomy with general anesthesia.Interventions: patients were randomly allocated to receive MgSO4 or saline intravenously (IV). Patients in the magnesium group received 50% MgSO4 (50 mg kg-1) in 100 mL saline and those in the control group received an equal volume of saline IV during the preoperative period followed by 50 mL hr-1 infusion of either MgSO4 (15 mg kg-1 hr-1) or saline until the end of surgery.Measurements and main results: Morphine requirement, pain during rest and on coughing, discomfort, and insomnia were assessed during the postoperative period for 24 hours. Intravenous morphine 40 μg kg-1 increments were given to all patients in the postoperative period for analgesia. Patients in the magnesium and control groups had similar morphine requirement during the first 24 hours postoperatively (p = 0.07). Patients in the magnesium group experienced less discomfort during the first hour after the operation. They also had better sleep quality during the first postoperative night than did the control group patients (p < 0.05). The frequency of side effects was similar in the two groups.Conclusion: Administration of intraoperative MgSO4 as an adjuvant analgesic in patients undergoing open cholecystectomy resulted in better pain relief and comfort in the first postoperative hour, but it did not significantly decrease the postoperative morphine requirement. Magnesium sulphate resulted in better sleep quality during the postoperative period, without any significant adverse effects. The role of MgSO4 as an adjuvant analgesic in open cholecystectomy needs to be studied further. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
4. No Benefits of Adding Dexmedetomidine, Ketamine, Dexamethasone, and Nerve Blocks to an Established Multimodal Analgesic Regimen after Total Knee Arthroplasty.
- Author
-
Muñoz-Leyva, Felipe, Jack, James M., Bhatia, Anuj, Chin, Ki Jinn, Gandhi, Rajiv, Perlas, Anahi, Jin, Rongyu, and Chan, Vincent
- Subjects
- *
RESEARCH , *FERRANS & Powers Quality of Life Index , *TOTAL knee replacement , *ANALGESICS , *DEXAMETHASONE , *RESEARCH methodology , *NERVE block , *EVALUATION research , *IMIDAZOLES , *MORPHINE , *COMPARATIVE studies , *RANDOMIZED controlled trials , *KETAMINE , *OPIOID analgesics , *POSTOPERATIVE pain , *LOCAL anesthetics - Abstract
Background: An optimal opioid-sparing multimodal analgesic regimen to treat severe pain can enhance recovery after total knee arthroplasty. The hypothesis was that adding five recently described intravenous and regional interventions to multimodal analgesic regimen can further reduce opioid consumption.Methods: In a double-blinded fashion, 78 patients undergoing elective total knee arthroplasty were randomized to either (1) a control group (n = 39) that received spinal anesthesia with intrathecal morphine, periarticular local anesthesia infiltration, intravenous dexamethasone, and a single injection adductor canal block or (2) a study group (n = 39) that received the same set of analgesic treatments plus five additional interventions: local anesthetic infiltration between the popliteal artery and capsule of the posterior knee, intraoperative intravenous dexmedetomidine and ketamine, and postoperatively, one additional intravenous dexamethasone bolus and two additional adductor canal block injections. The primary outcome measure was 24-h cumulative opioid consumption after surgery and secondary outcomes were other analgesics, patient recovery, functional outcomes, and adverse events.Results: Opioid consumption was not different between groups at 24 h (oral morphine equivalents, mean ± SD; study: 23.7 ± 18.0 mg vs. control: 29.3 ± 18.7 mg; mean difference [95% CI], -5.6 mg [-2.7 to 13.9]; P = 0.189) and all other time points after surgery. There were no major differences in pain scores, quality of recovery, or time to reach rehabilitation milestones. Hypotensive episodes occurred more frequently in the study group (25 of 39 [64.1%] vs. 13 of 39 [33.3%]; P = 0.010).Conclusions: In the presence of periarticular local anesthesia infiltration, intrathecal morphine, single-shot adductor canal block and dexamethasone, the addition of five analgesic interventions-local anesthetic infiltration between the popliteal artery and capsule of the posterior knee, intravenous dexmedetomidine, intravenous ketamine, an additional intravenous dexamethasone dose, and repeated adductor canal block injections-failed to further reduce opioid consumption or pain scores or to improve functional outcomes after total knee arthroplasty.Editor’s Perspective: [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
5. The State of Synthetic Cannabinoid Medications for the Treatment of Pain.
- Author
-
Maglaviceanu, Anca, Peer, Miki, Rockel, Jason, Bonin, Robert P., Fitzcharles, Mary-Ann, Ladha, Karim S., Bhatia, Anuj, Leroux, Timothy, Kotra, Lakshmi, Kapoor, Mohit, and Clarke, Hance
- Subjects
- *
PAIN management , *SYNTHETIC marijuana , *CANCER chemotherapy , *ANALGESICS , *DRUGS , *IMMUNOLOGICAL deficiency syndromes , *POSTOPERATIVE pain - Abstract
Synthetic cannabinoids are compounds made in the laboratory to structurally and functionally mimic phytocannabinoids from the
Cannabis sativa L. plant, including delta-9-tetrahydrocannabinol (THC). Synthetic cannabinoids (SCs) can signal via the classical endogenous cannabinoid system (ECS) and the greater endocannabidiome network, highlighting their signalling complexity and far-reaching effects. Dronabinol and nabilone, which mimic THC signalling, have been approved by the Food and Drug Administration (FDA) for treating nausea associated with cancer chemotherapy and/or acquired immunodeficiency syndrome (AIDS). However, there is ongoing interest in these two drugs as potential analgesics for a variety of other clinical conditions, including neuropathic pain, spasticity-related pain, and nociplastic pain syndromes including fibromyalgia, osteoarthritis, and postoperative pain, among others. In this review, we highlight the signalling mechanisms of FDA-approved synthetic cannabinoids, discuss key clinical trials that investigate their analgesic potential, and illustrate challenges faced when bringing synthetic cannabinoids to the clinic. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
6. Intrathecal Morphine and Pulmonary Complications after Arthroplasty in Patients with Obstructive Sleep Apnea: A Retrospective Cohort Study.
- Author
-
Bai, Johnny W., Singh, Mandeep, Short, Anthony, Bozak, Didem, Chung, Frances, Chan, Vincent W. S., Bhatia, Anuj, and Perlas, Anahi
- Subjects
- *
PAIN management , *NARCOTICS , *RESEARCH , *TOTAL hip replacement , *TOTAL knee replacement , *RESPIRATORY insufficiency , *SPINAL injections , *ANALGESICS , *RESEARCH methodology , *SURGICAL complications , *RETROSPECTIVE studies , *EVALUATION research , *MEDICAL cooperation , *MORPHINE , *COMPARATIVE studies , *PSYCHOLOGICAL tests , *SLEEP apnea syndromes , *PATIENT-family relations , *POSTOPERATIVE pain , *LONGITUDINAL method - Abstract
Background: Intrathecal morphine is commonly and effectively used for analgesia after joint arthroplasty, but has been associated with delayed respiratory depression. Patients with obstructive sleep apnea may be at higher risk of postoperative pulmonary complications. However, data is limited regarding the safety of intrathecal morphine in this population undergoing arthroplasty.Methods: This retrospective cohort study aimed to determine the safety of intrathecal morphine in 1,326 patients with documented or suspected obstructive sleep apnea undergoing hip or knee arthroplasty. Chart review was performed to determine clinical characteristics, perioperative events, and postoperative outcomes. All patients received neuraxial anesthesia with low-dose (100 μg) intrathecal morphine (exposure) or without opioids (control). The primary outcome was any postoperative pulmonary complication including: (1) respiratory depression requiring naloxone; (2) pneumonia; (3) acute respiratory event requiring consultation with the critical care response team; (4) respiratory failure requiring intubation/mechanical ventilation; (5) unplanned admission to the intensive care unit for respiratory support; and (6) death from a respiratory cause. The authors hypothesized that intrathecal morphine would be associated with increased postoperative complications.Results: In 1,326 patients, 1,042 (78.6%) received intrathecal morphine. The mean age of patients was 65 ± 9 yr and body mass index was 34.7 ± 7.0 kg/m. Of 1,326 patients, 622 (46.9%) had suspected obstructive sleep apnea (Snoring, Tired, Observed, Pressure, Body Mass Index, Age, Neck size, Gender [STOP-Bang] score greater than 3), while 704 of 1,326 (53.1%) had documented polysomnographic diagnosis. Postoperatively, 20 of 1,322 (1.5%) patients experienced pulmonary complications, including 14 of 1,039 (1.3%) in the exposed and 6 of 283 (2.1%) in the control group (P = 0.345). Overall, there were 6 of 1 322 (0.5%) cases of respiratory depression, 18 of 1,322 (1.4%) respiratory events requiring critical care team consultation, and 4 of 1,322 (0.3%) unplanned intensive care unit admissions; these rates were similar between both groups. After adjustment for confounding, intrathecal morphine was not significantly associated with postoperative pulmonary complication (adjusted odds ratio, 0.60 [95% CI, 0.24 to 1.67]; P = 0.308).Conclusions: Low-dose intrathecal morphine, in conjunction with multimodal analgesia, was not reliably associated with postoperative pulmonary complications in patients with obstructive sleep apnea undergoing joint arthroplasty. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.